missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Obexelimab Chimeric Recombinant Human Monoclonal Antibody

Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Obexelimab (XmAb5871) is a first-in-class monoclonal antibody that targets CD19 with its variable domain and uses the XmAb immune inhibitory Fc domain to target FcgammaRIIb, a receptor that inhibits B cell function. Obexelimab is the first pharmaceutical candidate to our knowledge that targets FcgammaRIIb inhibition.
Specifications
Specifications
| Antigen | Obexelimab Chimeric |
| Applications | ELISA, SDS-Page |
| Classification | Recombinant Monoclonal |
| Concentration | 1.57 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative; pH 7.4 |
| Gene Alias | XmAb5871 |
| Host Species | Human |
| Immunogen | Human CD19. |
| Purification Method | Protein A/G |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?